Medicare Enrolled

Dr. Annie Garaghty, D.O

Family Medicine · Sugar Land, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
16902 SOUTHWEST FWY STE 100, Sugar Land, TX 77479
2815652800
In practice since 2012 (13 years)
NPI: 1326309808 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Garaghty from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Garaghty? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Garaghty

Dr. Annie Garaghty is a family medicine specialist in Sugar Land, TX, with 13 years of NPI registration. Based on federal Medicare data, Dr. Garaghty performed 160 Medicare services across 138 unique beneficiaries.

Between the years covered by Open Payments, Dr. Garaghty received a total of $14,453 from 68 pharmaceutical and/or device companies across 755 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Garaghty is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ 160 Medicare services $14,453 industry payments

Medicare Practice Summary

Medicare Utilization ↗
160
Medicare services
Bottom 25% in TX for family medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
138
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~12 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Annual wellness visit, follow-up 56 $124 $250
Office visit, established patient (20-29 min) 47 $52 $135
Office visit, established patient (30-39 min) 43 $76 $160
Bone density scan (DEXA) 14 $36 $200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,453
Total received (2018-2024)
Avg $2,065/year across 7 years
Top 2% in TX for family medicine
68
Companies
755
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,453 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,158
2023
$1,979
2022
$1,875
2021
$2,101
2020
$1,749
2019
$2,261
2018
$2,329

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$1,719
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,139
Novo Nordisk Inc
$1,108
Lilly USA, LLC
$857
Amgen Inc.
$829
AstraZeneca Pharmaceuticals LP
$671
Amarin Pharma Inc.
$556
Teva Pharmaceuticals USA, Inc.
$528
OptiNose US, Inc.
$503
SANOFI-AVENTIS U.S. LLC
$479
ABBVIE INC.
$422
Merck Sharp & Dohme Corporation
$420
Janssen Pharmaceuticals, Inc
$412
GlaxoSmithKline, LLC.
$396
AbbVie Inc.
$384
Takeda Pharmaceuticals U.S.A., Inc.
$333
Astellas Pharma US Inc
$321
PFIZER INC.
$258
Bausch Health US, LLC
$225
Optinose US, Inc.
$213
Inspire Medical Systems, Inc.
$201
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$199
Bayer Healthcare Pharmaceuticals Inc.
$195
Eisai Inc.
$191
Bayer HealthCare Pharmaceuticals Inc.
$178
Shire North American Group Inc
$131
Saluda Medical Americas, Inc.
$115
AbbVie, Inc.
$107
Allergan, Inc.
$103
Radius Health, Inc.
$87
Dexcom, Inc.
$86
Genentech USA, Inc.
$82
Merck Sharp & Dohme LLC
$75
INTUITIVE SURGICAL, INC.
$73
Biohaven Pharmaceuticals, Inc.
$70
Biohaven Pharmaceutical Holding Company Ltd.
$62
Ironshore Pharmaceuticals Inc.
$54
SANOFI PASTEUR INC.
$51
Exact Sciences Corporation
$43
Seqirus USA Inc
$37
Amneal Pharmaceuticals LLC
$34
Verity Pharmaceuticals Inc.
$31
Clarus Therapeutics Inc.
$30
Gemini Laboratories, LLC
$27
Phathom Pharmaceuticals, Inc.
$26
Boston Scientific Corporation
$25
Supernus Pharmaceuticals, Inc.
$24
Kowa Pharmaceuticals America, Inc.
$22
Duchesnay USA Incorporated
$22
Dynavax Technologies Corporation
$21
Corcept Therapeutics
$20
Medtronic, Inc.
$20
SHIELD THERAPEUTICS INC
$18
PROCEPT BioRobotics Corporation
$18
Horizon Therapeutics plc
$17
Hologic, LLC
$17
Mylan Specialty L.P.
$16
Esperion Therapeutics, Inc.
$16
Corium, LLC
$16
EISAI INC.
$15
Neos Therapeutics, LP
$15
Orexigen Therapeutics, Inc.
$14
Phadia US Inc.
$14
Mission Pharmacal Company
$13
Nuvectra Corporation
$13
Shield Therapeutics Inc
$13
IDORSIA PHARMACEUTICALS US INC
$13
ARBOR PHARMACEUTICALS, INC.
$11
Top 3 companies account for 27.4% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADVAIR · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · APLENZIN · AQUABEAM SYSTEM · AREXVY · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Aimovig · AirDuo Digihaler · Algovita · Androgel · BELSOMRA · BEXSERO · BREO · BYDUREON · Bonjesta · CARDIOMEMS · CHANTIX · CINQAIR · CONTRAVE · CREON · CardioMEMS HF System · Cologuard Collection Kit · Confirm Rx · Da Vinci Surgical System · Dayvigo · Dexcom G6 Transmitter · EMGALITY · ETERNA · EVENITY · EVUSHELD · Evoke · FARXIGA · FLUBLOK QUADRIVALENT · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE QUADRIVALENT · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Ferralet · Flucelvax · FreeStyle Libre · FreeStyle Libre 2 · GARDASIL 9 · Heplisav-B · INSPIRE · INVOKANA · ImmunoCAP · Inspire Upper Airway Stimulation System · JANUVIA · JARDIANCE · JATENZO · Jornay PM 20mg capsules (Bottle of 100) · KRYSTEXXA · Kerendia · Korlym · LINZESS · LO LOESTRIN FE · LYRICA · Livalo · M-M-R II · MIGRANAL · MOTEGRITY · MOUNJARO · MYDAYIS · MYRBETRIQ · NEXLETOL · NURTEC ODT · Otezla · Otovel · Ozempic · PNEUMOVAX 23 · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PRODIGY · Prolia · QULIPTA · QUVIVIQ · QVAR · ROTATEQ · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STIOLTO RESPIMAT · SYNTHROID · Saxenda · Synthroid · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · ThinPrep · Tlando · Trintellix · Tymlos · UBRELVY · UNITHROID · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · VenaSeal · Veozah · Victoza · WATCHMAN · WELLBUTRIN · Wegovy · XARELTO · XIFAXAN · Xhance · Xofluza · Xultophy 100/3.6 · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in TX.

Equivalent to $9,033 per 100 Medicare services performed
Looking for a family medicine specialist in Sugar Land?
Compare family medicine physicians in the Sugar Land area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
1,306
Per 100K population
151.9
County median income
$113,409
Nearest hospital
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Garaghty is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 2% of TX peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Garaghty experienced with annual wellness visit, follow-up?
Based on Medicare claims data, Dr. Garaghty performed 56 annual wellness visit, follow-up services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Garaghty receive payments from pharmaceutical companies?
Yes. Dr. Garaghty received a total of $14,453 from 68 companies across 755 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Garaghty's costs compare to other family medicine physicians in Sugar Land?
Dr. Garaghty's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Garaghty) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →